Fcpm III Services B.V. reported 21 holdings worth US$1.06B as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Fcpm III Services B.V. reported 21 holdings worth US$1.06B as of Sep 30, 2026. Largest: Braveheart Bio, Inc., Vor Biopharma Inc. and Dyne Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 21
- Value as reported
- US$1.06B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Braveheart Bio, Inc. | 21.8M | US$441M | 41.6% |
| Vor Biopharma Inc. | 3.41M | US$65M | 6.1% |
| Dyne Therapeutics, Inc. | 3.59M | US$57.8M | 5.4% |
| Damora Therapeutics, Inc. | 2.44M | US$51.9M | 4.9% |
| MapLight Therapeutics, Inc. | 4.43M | US$45.1M | 4.3% |
| Aura Biosciences, Inc. | 5.25M | US$33M | 3.1% |
| Crescent Biopharma, Inc. | 2.02M | US$29.5M | 2.8% |
| Replimune Group, Inc. | 1.72M | US$22.8M | 2.1% |
| enGene Holdings Inc. | 9.63M | US$19.3M | 1.8% |
| Bicycle Therapeutics PLC | 3.47M | US$12.8M | 1.2% |
| Tarsus Pharmaceuticals, Inc. | 64,087 | US$5.04M | 0.47% |
| Lisata Therapeutics, Inc. | 297K | US$428K | 0.04% |
Source
Download original · View original at SEC